Page 42 - Michael Erman News Today

By Michael Erman and Julie Steenhuysen NEW YORK (Reuters) - Drugmakers including Pfizer Inc, GlaxoSmithKline PLC, Bristol Myers Squibb, AstraZeneca PL...

By Sriparna Roy and Michael Erman (Reuters) - An influential drug pricing research group has cut its suggested price range for Pfizer Inc's COVID-19 a...

By Sriparna Roy and Michael Erman (Reuters) - An influential drug pricing research group has cut its suggested price range for Pfizer Inc's COVID-19 a...

(Reuters) - AbbVie Inc is leaving Pharmaceutical Research and Manufacturers of America (PhRMA), the leading U.S. drug industry group said on Thursday....

(Reuters) - The U.S. government agreed to pay drugmaker Pfizer Inc nearly $2 billion for an additional 3.7 million courses of its COVID-19 antiviral d...

(Reuters) - Drugmaker Pfizer Inc said on Tuesday it is working to improve supply of its COVID-19 antiviral drug Paxlovid in China in order to ensure a...

Drugmaker Pfizer said on Tuesday it is working to improve supply of its COVID-19 antiviral drug Paxlovid in China in order to ensure adequate access to the drug as cases rise in the country.

The US government agreed to pay Pfizer nearly $2 billion for an additional 3.7 million courses of its COVID-19 antiviral treatment Paxlovid, the company said on Tuesday.

(Reuters) - Drugmaker Pfizer Inc said on Tuesday it is working to improve supply of its COVID-19 antiviral drug Paxlovid in China in order to ensure a...

An experimental cancer vaccine from Moderna based on mRNA technology has been shown to work against melanoma, sending Moderna shares more than 20% higher.